Windtree Therapeutics, Inc.
WINT
$1.20
-$0.10-7.69%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.71M | -11.38M | -5.96M | -20.29M | -24.83M |
| Total Depreciation and Amortization | 485.00K | 442.00K | 389.00K | 391.00K | 393.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.52M | -5.87M | -10.84M | 4.45M | 10.90M |
| Change in Net Operating Assets | 1.46M | 4.12M | 2.55M | 2.02M | 285.00K |
| Cash from Operations | -15.28M | -12.69M | -13.87M | -13.44M | -13.25M |
| Capital Expenditure | -12.00K | -27.00K | -15.00K | -15.00K | -15.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.00K | -27.00K | -15.00K | -15.00K | -15.00K |
| Total Debt Issued | 1.86M | 1.66M | -- | -- | -- |
| Total Debt Repaid | -928.00K | -700.00K | -778.00K | -797.00K | -940.00K |
| Issuance of Common Stock | 10.42M | 2.12M | 12.92M | 12.39M | 13.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -847.00K | -- | -- | -- | -- |
| Total Dividends Paid | -347.00K | -- | -- | -- | -- |
| Other Financing Activities | -68.00K | -168.00K | -100.00K | -- | -- |
| Cash from Financing | 10.09M | 2.92M | 12.04M | 11.60M | 12.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.21M | -9.81M | -1.84M | -1.86M | -1.08M |
